首页> 美国政府科技报告 >Challenge and Opportunity on the Critical Path to New Medical Products
【24h】

Challenge and Opportunity on the Critical Path to New Medical Products

机译:新医疗产品关键路径的挑战与机遇

获取原文

摘要

This report provides the Food and Drug Administration's (FDAs) analysis of the pipeline problem the recent slowdown, instead of the expected acceleration, in innovative medical therapies reaching patients. This report replaces the version posted on March 16, 2004. It contains a revised Figure 2, which now reflects fiscal year data for both BLAs and NMEs, and minor editorial changes.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号